(1) The scope of an Agreement shall NOT include:
- (a) Any person or patient of a Collaborating Physician for whom such Collaborating Physician has not prepared a patient-specific, drug- or drug class-specific, disease-specific, or condition-specific plan of care based on a physical examination of the patient by the Collaborating Physician within the past twelve (12) months, with the exception of immunizations and acute, uncomplicated illness or injury as well as the dispensing of opioid antagonists as defined in Code of Ala. 1975, §20-2-280; or
- (b) The prescribing of controlled substances listed or to be listed in the schedules under federal law and in Code of Ala. 1975, §§20-2-23, 20-2-25, 20-2-27, 20-2-29, and 20-2-31 and/or Ala. Admin. Code r. 420-7-2 and its Appendix.
- (2) No retail pharmacy may employ a physician for the purpose of maintaining, establishing, or entering into a collaborative practice agreement. Nothing shall prohibit a retail pharmacy from hiring a physician or licensed medical practitioner for the purpose of conducting quality assurance reviews of its pharmacists that are engaged in the practice of collaborative drug therapy.
- (3) A Collaborating Physician may collaborate with a maximum of three Collaborating Pharmacists for testing or screening for and treatment of acute, uncomplicated illness or injury.
- (4) A Collaborating Pharmacist may collaborate with a maximum of three Collaborating Physicians for testing or screening for and treatment of acute, uncomplicated illness or injury.
Author: Alabama Board of Medical Examiners
Statutory Authority: Code of Ala. 1975, §34-24-53; Act 2019-368
(Code of Ala. 1975, §34-23-77).
History: New Rule: Published August 31, 2021; effective October 15, 2021. Amended: Published November 30, 2023; effective January 14, 2024. Amended: Published September 30, 2024; effective November 14, 2024.